Lotus Pharmaceutical (stock code: 1795 TT) is a fast-growing specialty pharmaceutical company headquartered in Taiwan. As one of the largest specialty pharma companies in the region, Lotus focuses on developing, manufacturing, in-licensing and commercialising high-quality medicines across 90+ markets in the world. With best-in-class R&D capabilities and strong manufacturing platforms, Lotus combines innovation and efficiency under one integrated network. Through its hybrid portfolio strategy — balancing in-house R&D with strategic business development — Lotus continues to build an optimised, sustainable pipeline of specialty and complex products.
Lotus Pharmaceutical Announces 505(b)(2) NDA Filing for LP757 (Cabozantinib)
